High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors

Louis PerolHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Eric GrignanoHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Adrien ContejeanHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Lauris GastaudHematology Department, Antoine Lacassagne Cancer Center, Nice, France

Marielle LegoffHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Patricia FranchiHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Bénédicte Deau-FischerHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Lise WillemsHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Didier BouscaryHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France;

Jerome TamburiniHematology Department, Cochin Hospital, Paris, France; ;Paris Descartes University, Paris, France; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgments

We thank Dr. Mark A. Murakami, MD (Dana-Farber Cancer Institute, Boston, USA) for his insightful comments on our manuscript.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1577414.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors

Information for

Open access

Opportunities

Help and information

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors

Acknowledgments

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature